KALY recently announced a contract with a New York State Licensed Hemp Cultivation Operation anticipated to generate an estimated $5 million in revenue for KALY.
Extraction Business Adds to KALY Pharma Business and PURA and USMJ Partnerships
DALLAS, June 17, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) plans to expand its CBD extraction business to $20 million in 2019 sales.
KALY recently announced a contract with a New York State Licensed Hemp Cultivation Operation anticipated to generate an estimated $5 million in revenue for KALY.
Today, based on an NBC News Report, KALY’s hemp derived CBD extraction business seems more than ever to be on point in the State of New York. The report highlights a major farming movement in New York toward hemp cultivation. Management is remaining open to the potential of raising its 2019 $20 million CBD extraction target.
See KALY’s full plan to expand its extraction business to $20 million in sales:
